Shares of Vitamin Shoppe, Inc (NYSE:VSI) traded up 9% during trading on Friday . The stock traded as high as $6.05 and last traded at $6.05. 1,770,787 shares changed hands during trading, an increase of 172% from the average session volume of 651,939 shares. The stock had previously closed at $5.55.

Several analysts have commented on the company. Morgan Stanley set a $8.00 price objective on Vitamin Shoppe and gave the company a “hold” rating in a research note on Thursday, August 10th. Goldman Sachs Group, Inc. (The) reaffirmed a “sell” rating and set a $6.00 price objective (down from $13.00) on shares of Vitamin Shoppe in a research note on Thursday, August 10th. TheStreet downgraded Vitamin Shoppe from a “c-” rating to a “d” rating in a research note on Wednesday, August 9th. BidaskClub downgraded Vitamin Shoppe from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Finally, ValuEngine downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Four investment analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $14.38.

The stock has a 50-day moving average price of $6.83 and a 200 day moving average price of $13.23. The firm’s market capitalization is $140.50 million.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.39 by ($0.16). The business had revenue of $304.84 million for the quarter, compared to the consensus estimate of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The business’s quarterly revenue was down 8.4% on a year-over-year basis. During the same period last year, the firm posted $0.55 EPS. On average, analysts anticipate that Vitamin Shoppe, Inc will post $0.79 earnings per share for the current year.

In other Vitamin Shoppe news, Director John D. Bowlin purchased 40,000 shares of the business’s stock in a transaction dated Friday, August 25th. The shares were bought at an average price of $5.50 per share, with a total value of $220,000.00. Following the completion of the acquisition, the director now owns 56,028 shares in the company, valued at approximately $308,154. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.07% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Mason Street Advisors LLC raised its holdings in shares of Vitamin Shoppe by 7.0% during the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares during the last quarter. BNP Paribas Arbitrage SA raised its holdings in shares of Vitamin Shoppe by 2.1% during the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares during the last quarter. Municipal Employees Retirement System of Michigan raised its holdings in shares of Vitamin Shoppe by 18.1% during the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock valued at $110,000 after buying an additional 1,440 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Vitamin Shoppe during the first quarter valued at approximately $208,000. Finally, Wolverine Trading LLC bought a new stake in shares of Vitamin Shoppe during the second quarter valued at approximately $131,000. 96.86% of the stock is currently owned by institutional investors.

WARNING: This piece of content was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/09/15/vitamin-shoppe-inc-vsi-trading-9-higher.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.